Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn®
Friday, October 23, 2020Catalent the leading global provider of advanced delivery technologies development and manufacturing solutions for drugs biologics cell and gene therapies and consumer health products and BrainStorm Cell Therapeutics Inc a leading developer of cellul...
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices
Friday, October 23, 2020Avalon GloboCare Corp a clinicalstage global developer of cellbased technologies and therapeutics and Adial Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on the development of treatments for addiction
Teneobio Announces a Research Collaboration and License Agreement With ArsenalBio
Thursday, October 22, 2020Teneobio Inc a clinicalstage biotechnology company developing engineered bispecific antibodies to treat cancer announced that it has entered into a research collaboration and commercial license agreement with ArsenalBio for the use of Teneobios UniDa...
HemoShear Therapeutics Enters into Rare Liver Disease Research Collaboration with Takeda
Thursday, October 22, 2020HemoShear Therapeutics LLC a privately held clinical stage biotechnology company has entered into a research collaboration and service agreement with Takeda Pharmaceutical Company Limited Takeda
Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease
Wednesday, October 21, 2020Prothena Corporation plc a latestage clinical company with expertise in protein dysregulation and a diverse pipeline of investigational therapeutics for neurodegenerative and rare peripheral amyloid diseases announced that based on positive signals o...
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
Wednesday, October 21, 2020Cytocom Inc Cytocom a leading biopharmaceutical company in the area of immunemodulation and Cleveland BioLabs Inc an innovative biopharmaceutical company developing novel approaches to activate the immune system today announced that they have entered...
Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech
Tuesday, October 20, 2020Genesis Therapeutics a privatelyheld company inventing and deploying stateoftheart artificial intelligence AI techniques to augment drug discovery and development today announced that it has entered into a multitarget collaboration agreement with Gen...
NGM Expands Oncology Portfolio with First Immuno-Oncology Development Candidate, NGM707, a Novel Dual Antagonist Antibody Inhibiting ILT2 and ILT4
Tuesday, October 20, 2020ORIC Pharmaceuticals Inc a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance today announced it has entered into an exclusive license agreement with Voronoi Inc an innovative drug disco...
Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment
Monday, October 19, 2020Akron Biotechnology today announced it has signed an agreement with Synairgen plc LSE SNG for the provision of SNG Synairgens whollyowned inhaled interferon beta IFNbeta therapeutic candidate for the treatment of COVID patients Akron Biotech provides...
Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Saturday, October 17, 2020Orchard Therapeutics a global gene therapy leader announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending full or standard marketing authorization for Lib...
